Pablo de la Cueva-Dobao

17PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyMultimorbidityCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 13, 2026
Prognostic Impact of Detection Patterns, Reasons for Consultation, and Sex Differences in Melanoma Among Young Adults: A 30-Year Retrospective Cohort Study.

|May 27, 2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).

|Apr 18, 2026
Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral.

|Sep 11, 2025
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review.

Ofelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull

|Jul 31, 2025
Retrospective study of onychomycosis patients treated with ciclopirox 8% HPCH and oral antifungals applying artificial intelligence to electronic health records.

Gastón Roustan, José Luis López Estébaranz, Pablo De La Cueva

|Jul 18, 2025
Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology.

Esteban Daudén, Isabel Belinchón, Elena Colominas-González

Pageof 3

Frequent Collaborators

6 joint publications

Esteban Daudén

6 joint publications

Isabel Belinchón-Romero

6 joint publications

Raquel Rivera-Diaz

5 joint publications

Mar Llamas-Velasco